News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Opinion: How to Avoid Legal Problems in Collaborative Research
Catherine Coombes | Aug 31, 2016
A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.
Theranos CEO Presents New Device
Kerry Grens | Aug 2, 2016
The troubled firm’s medical conference appearance didn’t deliver the evidence many hoped for.
The Growth of Iowa Biotech
Jenny Rood | Aug 1, 2016
The state’s industry draws inspiration from medicine as well as agriculture.
23andMe Markets Genome Kits to Researchers
Kerry Grens | Jul 14, 2016
Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.
Jennifer Lawrence to Star in Theranos Movie
Tanya Lewis | Jun 13, 2016
The actress will portray the troubled blood testing startup’s founder, Elizabeth Holmes.
$1.5 Billion Pharma Buyout for Leukemia Drug
Jef Akst | Jun 1, 2016
Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.
Biotech Sponsors Science Competition
Tanya Lewis | May 26, 2016
Regeneron Pharmaceuticals takes over from Intel as the sponsor of the Science Talent Search.
Report: Still Lots to Learn About GE Crops
Tracy Vence | May 17, 2016
A National Academies–led analysis evaluates the impacts of genetically engineered crops—and calls for updated regulations.
Another Gene-Editing IPO
Bob Grant | Apr 12, 2016
Intellia Therapeutics, which seeks to develop CRISPR-based technologies to target rare diseases, is hoping to raise $120 million in an initial public offering.
Inaccurate Cholesterol Tests from Theranos
Jef Akst | Mar 29, 2016
The company’s finger-prick tests yield cholesterol levels notably lower than results of traditional blood draw tests from two other large companies, according to a study.